Challenge And Innovation


Thank you very much for your continued and significant support to Complex Cardiovascular Therapeutics (CCT). I, Yasumi Igarashi, would like to extend my brief greeting to all of you as I have been appointed to a chairperson.

With the purpose of challenging the PCI treatment for complicated coronary artery lesions, the CCT was founded in 2001 and was developed from its predecessor, Complex Coronary Intervention Conference (CCIC) and the Naka-nihon Live in 1990’s. We have consistently focused on the PCI treatment for complex coronary artery lesions such as chronic total occlusions and left main coronary artery diseases since the CCT foundation to the present date. We have been enriching a wide variety of programs for PPI treatment, structural heart diseases, surgical treatment, and delivering the information to Japan and the entire world through live demonstrations.

Last year, we had the largest number of over 5,500 participants since the foundation of the CCT. We believe that this is because our activities were supported by you. In the future, we will continue to disseminate information originating in Japan with the aim of further developing the CCT on the theme of “new challenges” while passing on the achievement of predecessors who have developed the CCT, to the next generation.

We would like to ask for your continued support to assist us in reaching our goals. We look forward to seeing you in Kobe in October, 2019.

(June 5, 2019)

Board Chairperson of the General Incorporated Association CCT
Yasumi Igarashi (Tokeidai Memorial Hospital)

CCT Administration Office

Central Residence 201, 48 Higashiodawaracho, Toyohashi, Aichi 440-0886, Japan
TEL:+81-532-57-1275 / FAX:+81-532-52-2883 / E-mail: